Print Page  |  Close Window

SEC Filings

8-K
MEDPACE HOLDINGS, INC. filed this Form 8-K on 12/08/2016
Entire Document
 

[Plus] [Minus]20

 

4.Notwithstanding anything to the contrary and without duplication of any adjustments provided for in paragraphs (I)(A)(1) to (I)(A)(3) above, to the extent that such amounts were included in the determination of Consolidated Net Income, any calculation of Consolidated EBITDA shall exclude for any period, any income (loss) for such period attributable to the early extinguishment of (i) Indebtedness, (ii) obligations under any Swap Contracts and (iii) other derivative instruments.

$_____

5.Total Consolidated EBITDA

$_____

B.Consolidated Funded Indebtedness:

$_____

 

 

C.Unrestricted cash and Cash Equivalents

 

1.The unrestricted cash and Cash Equivalents of the Restricted Group as of such date of determination in an amount not to exceed $50,000,000, of which not more than $25,000,000 shall be foreign cash and Cash Equivalents

$_____

D.Total Net Leverage Ratio ((Line I.B – Line I.C.1) ÷ Line I.A.5):

_____

 

II.Section 7.10(b) of the Credit Agreement – Minimum Interest Coverage Ratio.

 

A.Consolidated EBITDA (Line I.A.5):

$_____

B.Consolidated Interest Expense:

$_____

C.Interest Coverage Ratio (Line II.A ÷ Line II.B):

_____

 

 

 

 

 

 

 

20 

To be determined based on net result of I.A.4.

 

 

Schedule 2-6

 

 

84402209_5